Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data.
Chen Z, Chen Y, Sun Y, Tang L, Zhang L, Hu Y, He M, Li Z, Cheng S, Yuan J, Wang Z, Wang Y, Zhao J, Gong J, Zhao L, Cao B, Li G, Zhang X, Dong B, Shen L.
Chen Z, et al.
Signal Transduct Target Ther. 2024 Aug 26;9(1):222. doi: 10.1038/s41392-024-01932-y.
Signal Transduct Target Ther. 2024.
PMID: 39183247
Free PMC article.